<DOC>
	<DOC>NCT00671268</DOC>
	<brief_summary>Efficacy and Safety from a high-dosed subcutaneous recombinant preparation</brief_summary>
	<brief_title>Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>Allergic rhinoconjunctivitis attributable to grass pollen Positive SPT Positive EAST Positive provocation test serious disease other perennial allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Grass pollen allergy</keyword>
	<keyword>specific immunotherapy</keyword>
</DOC>